+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Results for tag: "Protein Drugs"

From
From
From
From
Biologics Market - Forecasts from 2024 to 2029 - Product Thumbnail Image

Biologics Market - Forecasts from 2024 to 2029

  • Report
  • April 2024
  • 121 Pages
  • Global
From
From
From
From
From
From
From
From
PEGylated Proteins Market - Product Thumbnail Image

PEGylated Proteins Market

  • Report
  • May 2024
  • 200 Pages
  • Global
From
Biopharmaceuticals Contract Manufacturing Market - Product Thumbnail Image

Biopharmaceuticals Contract Manufacturing Market

  • Report
  • May 2024
  • 200 Pages
  • Global
From
From
Loading Indicator

The Protein Drugs market is a subset of the larger Drug Discovery industry. It focuses on the development of drugs that are based on proteins, such as monoclonal antibodies, cytokines, and growth factors. These drugs are used to treat a variety of diseases, including cancer, autoimmune disorders, and infectious diseases. Protein drugs are typically developed through recombinant DNA technology, which involves the manipulation of genetic material to create a desired protein. The Protein Drugs market is highly competitive, with many companies vying for a share of the market. Companies in the market include AbbVie, Amgen, AstraZeneca, Biogen, Bristol-Myers Squibb, Eli Lilly, GlaxoSmithKline, Merck, Novartis, Pfizer, and Roche. These companies are engaged in research and development of new protein drugs, as well as the marketing and distribution of existing drugs. Show Less Read more